POVELLYS Trademark

Trademark Overview

On Thursday, February 27, 2020, a trademark application was filed for POVELLYS with the United States Patent and Trademark Office. The USPTO has given the POVELLYS trademark a serial number of 88813219. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 11, 2023. This trademark is owned by Pfizer Inc.. The POVELLYS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
povellys

General Information

Serial Number88813219
Word MarkPOVELLYS
Filing DateThursday, February 27, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 16, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, March 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, September 11, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 11, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 28, 2023SOU EXTENSION 5 GRANTED
Tuesday, January 10, 2023SOU EXTENSION 5 FILED
Thursday, January 26, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 10, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 12, 2022SOU EXTENSION 4 GRANTED
Tuesday, July 12, 2022SOU EXTENSION 4 FILED
Tuesday, July 12, 2022SOU TEAS EXTENSION RECEIVED
Saturday, January 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 6, 2022SOU EXTENSION 3 GRANTED
Thursday, January 6, 2022SOU EXTENSION 3 FILED
Thursday, January 6, 2022SOU TEAS EXTENSION RECEIVED
Saturday, July 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 22, 2021SOU EXTENSION 2 GRANTED
Thursday, July 22, 2021SOU EXTENSION 2 FILED
Thursday, July 22, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, January 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 8, 2021SOU EXTENSION 1 GRANTED
Friday, January 8, 2021SOU EXTENSION 1 FILED
Friday, January 8, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, August 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 16, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 16, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 27, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 14, 2020ASSIGNED TO EXAMINER
Sunday, March 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 5, 2020NEW APPLICATION ENTERED

Related Keywords

povellys preparations disorders pharmaceutical dysfunction treatment liver erectile blood viral urological